About this book:

This book, "Cancer Genomics Clinic: From Tumor Profiling to Targeted Therapies," serves as a comprehensive guide for clinicians navigating the complexities of personalized oncology. It details the journey from initial specimen acquisition and advanced sequencing technologies (targeted panels, WES, WGS, and RNA-Seq) through bioinformatics pipelines and quality control. A core focus is on the critical distinction between somatic and germline variants, their interpretation, management of incidental findings, and the necessity of genetic counseling. The book elucidates various variant classification and actionability frameworks, demonstrating how to translate complex genomic reports into prioritized therapeutic hypotheses.

The text delves into the intricate biology of cancer, identifying oncogenic drivers and pathways that serve as drug targets, and explores the diverse mechanisms of resistance—intrinsic, acquired, and bypass signaling—that challenge therapeutic efficacy. It highlights the growing importance of immuno-oncology biomarkers beyond PD-L1, such as tumor mutational burden (TMB), microsatellite instability (MSI), homologous recombination deficiency (HRD), tumor-infiltrating lymphocytes (TILs), and gene expression profiles (GEPs). A significant portion is dedicated to the practical application of liquid biopsy, detailing its use for monitoring response, detecting minimal residual disease (MRD), and identifying relapse, emphasizing its role as a non-invasive, dynamic monitoring tool.

Operational aspects of precision oncology are also thoroughly covered, including the vital role of multidisciplinary tumor boards, complete with workflows and checklists for deliberation. The book addresses critical considerations for special populations like pediatric and geriatric patients, and those with rare cancers, highlighting tailored approaches to testing, dosing, and toxicity management. It tackles the often-overlooked yet crucial issues of health equity and access, discussing coverage, reimbursement, and the importance of patient navigation to ensure that all patients can benefit from genomic insights. Ethical considerations, informed consent, and data governance in molecular oncology are explored, emphasizing transparency and patient autonomy.

Ultimately, the book integrates real-world evidence from registries and pragmatic trials to showcase the practical outcomes of genomics-guided therapy, offering decision algorithms for common clinical scenarios through illustrative case studies. It concludes by looking toward the future, anticipating emerging modalities like long-read and single-cell sequencing, spatial transcriptomics, advanced liquid biopsy applications, and the increasing role of artificial intelligence in shaping precision oncology. The overarching goal is to equip clinicians with the knowledge and tools to confidently transform genomic data into safe, effective, and equitable personalized treatment plans.

What You'll Find Inside:

• Provides a practical, clinically-focused guide to translating tumor genomic profiles into targeted treatment decisions, covering test selection, variant interpretation, and therapy sequencing.
• Details the entire molecular profiling workflow, from specimen acquisition and sequencing technologies to bioinformatics pipelines, quality control, and the interpretation of somatic vs. germline findings.
• Explores key biomarkers that guide both targeted and immunotherapy, including oncogenic drivers, resistance mechanisms, tumor mutational burden (TMB), microsatellite instability (MSI), and homologous recombination deficiency (HRD).
• Offers operational guidance for implementing precision oncology, including navigating genomic reports, managing toxicities, conducting tumor boards, and addressing health equity, coverage, and reimbursement challenges.
• Includes real-world case studies and decision algorithms that illustrate the application of genomic principles to common clinical scenarios, from newly diagnosed advanced cancers to managing resistance.

Who's It For:

This book is an essential resource for medical oncologists, clinical pathologists, molecular pathologists, and genetic counselors who are actively involved in cancer genomics and personalized medicine. It is specifically designed for clinicians who must translate complex genomic reports into practical treatment plans, making it ideal for oncologists working in both academic and community settings who manage patients with advanced solid tumors. The practical, hands-on approach with algorithms, checklists, and case studies also benefits advanced practice providers, pharmacists, and members of molecular tumor boards who need a clear framework for integrating molecular data into clinical decision-making.